Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome
Bo Angelin, Jens D. Kristensen, Mats Eriksson, Bo Carlsson, Irwin Klein, Anders G. Olsson, E. Chester Ridgway, Paul W. Ladenson
Dive into the research topics of 'Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome'. Together they form a unique fingerprint.